{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T21:16:11Z","timestamp":1770326171914,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12957-016-0837-1","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T04:53:37Z","timestamp":1457412817000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Neoadjuvant imatinib treatment and laparoscopic anus-preserving surgery for a large gastrointestinal stromal tumor of the rectum"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7961-3704","authenticated-orcid":false,"given":"Kennoki","family":"Kyo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiro","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Shimamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Maema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Kanamaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoaki","family":"Shirakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Shinmura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Koda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetaro","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,8]]},"reference":[{"key":"837_CR1","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.ejca.2011.08.008","volume":"47","author":"G Gatta","year":"2011","unstructured":"Gatta G, van der Zwan JM, Casali PG, Siesling S, Dei Tos AP, Kunkler I, et al. Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer. 2011;47:2493\u2013511.","journal-title":"Eur J Cancer"},{"key":"837_CR2","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.5858\/2006-130-1466-GSTROM","volume":"130","author":"M Miettinen","year":"2006","unstructured":"Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130:1466\u201378.","journal-title":"Arch Pathol Lab Med"},{"key":"837_CR3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","volume":"279","author":"S Hirota","year":"1998","unstructured":"Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279:577\u201380.","journal-title":"Science"},{"key":"837_CR4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-3565(24)38879-2","volume":"295","author":"E Buchdunger","year":"2000","unstructured":"Buchdunger E, Cioffi CL, Law N, Stover D, Ohno-Jones S, Druker BJ, et al. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther. 2000;295:139\u201345.","journal-title":"J Pharmacol Exp Ther"},{"key":"837_CR5","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM200104053441404","volume":"344","author":"H Joensuu","year":"2001","unstructured":"Joensuu H, Roberts PJ, Sarlomo-Rikala M, Andersson LC, Tervahartiala P, Tuveson D, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med. 2001;344:1052\u20136.","journal-title":"N Engl J Med"},{"key":"837_CR6","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1463-1318.2010.02442.x","volume":"13","author":"S Machlenkin","year":"2011","unstructured":"Machlenkin S, Pinsk I, Tulchinsky H, Ziv Y, Sayfan J, Duek D, et al. The effect of neoadjuvant imatinib therapy on outcome and survival after rectal gastrointestinal stromal tumour. Colorectal Dis. 2011;13:1110\u20135.","journal-title":"Colorectal Dis"},{"key":"837_CR7","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1245\/s10434-012-2647-1","volume":"20","author":"J Jakob","year":"2013","unstructured":"Jakob J, Mussi C, Ronellenfitsch U, Wardelmann E, Negri T, Gronchi A, et al. Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib. Ann Surg Oncol. 2013;20:586\u201392.","journal-title":"Ann Surg Oncol"},{"key":"837_CR8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/1477-7819-12-211","volume":"12","author":"H Nozawa","year":"2014","unstructured":"Nozawa H, Kanazawa T, Tanaka T, Takahashi M, Ishihara S, Sunami E, et al. Laparoscopic resection of a gastrointestinal stromal tumor of the lower rectum in a patient with coronary artery disease following long-term neoadjuvant imatinib treatment and anticoagulation therapy. World J Surg Oncol. 2014;12:211.","journal-title":"World J Surg Oncol"},{"key":"837_CR9","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/DCR.0000000000000146","volume":"57","author":"T Akiyoshi","year":"2014","unstructured":"Akiyoshi T, Ueno M, Fukunaga Y, Nagayama S, Fujimoto Y, Konishi T, et al. Laparoscopic local excision and rectoanal anastomosis for rectal gastrointestinal stromal tumor: modified laparoscopic intersphincteric resection technique. Dis Colon Rectum. 2014;57:900\u20134.","journal-title":"Dis Colon Rectum"},{"key":"837_CR10","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Soft Tissue Sarcoma. Version 1. 2015 http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/sarcoma.pdf ."},{"key":"837_CR11","doi-asserted-by":"crossref","first-page":"iii21","DOI":"10.1093\/annonc\/mdu255","volume":"25 Suppl 3","author":"The ESMO\/European Sarcoma Networking Group","year":"2014","unstructured":"The ESMO\/European Sarcoma Networking Group. Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25 Suppl 3:iii21\u20136.","journal-title":"Ann Oncol"},{"key":"837_CR12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s10147-007-0746-y","volume":"13","author":"T Nishida","year":"2008","unstructured":"Nishida T, Shirao K, Sawaki A, Koseki M, Okamura T, Ohtsu A, et al. Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202). Int J Clin Oncol. 2008;13:244\u201351.","journal-title":"Int J Clin Oncol"},{"key":"837_CR13","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1200\/JCO.2007.13.4403","volume":"26","author":"CD Blanke","year":"2008","unstructured":"Blanke CD, Demetri GD, von Mehren M, Heinrich MC, Eisenberg B, Fletcher JA, et al. Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT. J Clin Oncol. 2008;26:620\u20135.","journal-title":"J Clin Oncol"},{"key":"837_CR14","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1245\/s10434-013-3013-7","volume":"20","author":"P Rutkowski","year":"2013","unstructured":"Rutkowski P, Gronchi A, Hohenberger P, Bonvalot S, Sch\u00f6ffski P, Bauer S, et al. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience. Ann Surg Oncol. 2013;20:2937\u201343.","journal-title":"Ann Surg Oncol"},{"key":"837_CR15","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s10147-008-0798-7","volume":"13","author":"T Nishida","year":"2008","unstructured":"Nishida T, Hirota S, Yanagisawa A, Sugino Y, Minami M, Yamamura Y, et al. Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version. Int J Clin Oncol. 2008;13:416\u201330.","journal-title":"Int J Clin Oncol"},{"key":"837_CR16","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.ejca.2006.01.030","volume":"42","author":"M Debiec-Rychter","year":"2006","unstructured":"Debiec-Rychter M, Sciot R, Le Cesne A, Schlemmer M, Hohenberger P, van Oosterom AT, et al. KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. Eur J Cancer. 2006;42:1093\u2013103.","journal-title":"Eur J Cancer"},{"key":"837_CR17","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1200\/JCO.2008.17.4284","volume":"26","author":"MC Heinrich","year":"2008","unstructured":"Heinrich MC, Owzar K, Corless CL, Hollis D, Borden EC, Fletcher CD, et al. Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group. J Clin Oncol. 2008;26:5360\u20137.","journal-title":"J Clin Oncol"},{"key":"837_CR18","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(04)17098-0","volume":"364","author":"J Verweij","year":"2004","unstructured":"Verweij J, Casali PG, Zalcberg J, LeCesne A, Reichardt P, Blay JY, et al. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet. 2004;364:1127\u201334.","journal-title":"Lancet"},{"key":"837_CR19","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1007\/s10350-004-0687-8","volume":"47","author":"CR Changchien","year":"2004","unstructured":"Changchien CR, Wu MC, Tasi WS, Tang R, Chiang JM, Chen JS, et al. Evaluation of prognosis for malignant rectal gastrointestinal stromal tumor by clinical parameters and immunohistochemical staining. Dis Colon Rectum. 2004;47:1922\u20139.","journal-title":"Dis Colon Rectum"},{"key":"837_CR20","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/01.sla.0000219739.11758.27","volume":"243","author":"YW Novitsky","year":"2006","unstructured":"Novitsky YW, Kercher KW, Sing RF, Heniford BT. Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors. Ann Surg. 2006;243:738\u201345.","journal-title":"Ann Surg"},{"key":"837_CR21","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/archsurg.2009.108","volume":"144","author":"CE Woodall 3rd","year":"2009","unstructured":"Woodall 3rd CE, Brock GN, Fan J, Byam JA, Scoggins CR, McMasters KM, et al. An evaluation of 2537 gastrointestinal stromal tumors for a proposed clinical staging system. Arch Surg. 2009;144:670\u20138.","journal-title":"Arch Surg"},{"key":"837_CR22","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.5754\/hge10018","volume":"58","author":"M Tokunaga","year":"2011","unstructured":"Tokunaga M, Ohyama S, Hiki N, Fukunaga T, Yamamoto N, Yamaguchi T. Incidence and prognostic value of lymph node metastasis on c-Kit-positive gastrointestinal stromal tumors of the stomach. Hepatogastroenterology. 2011;58:1224\u20138.","journal-title":"Hepatogastroenterology"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-016-0837-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T17:33:35Z","timestamp":1748799215000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjso.com\/content\/14\/1\/68"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,8]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["837"],"URL":"https:\/\/doi.org\/10.1186\/s12957-016-0837-1","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,8]]},"article-number":"68"}}